deltatrials
Terminated NA INTERVENTIONAL NCT00428441

D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism

The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study

Sponsor: Università degli Studi dell'Insubria

Interventions Warfarin
Updated 5 times since 2017 Last updated: Aug 18, 2011 Started: May 31, 2007 Primary completion: Jun 30, 2010 Completion: May 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Enrolment was halted prematurely because of the observed excess in recurrences

Listed as NCT00428441, this NA trial focuses on Venous Thromboembolism and remains terminated or withdrawn. Sponsored by Università degli Studi dell'Insubria, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated NA

    First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Università degli Studi dell'Insubria
Data source: Università degli Studi dell'Insubria

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations